TMCnet News
PHT Corporation Hosts Upcoming Educational Webinar, "Effective Use of Electronic Patient Reported Outcomes (ePRO) in Migraine and Headache Patient Populations"BOSTON, Mass. and GENEVA, Switzerland --(Business Wire)-- Senior Scientific Advisors Dr. Susan M. Dallabrida and Dr. Jill Platko of PHT Consulting Services will conduct a new webinar, "Effective Use of Electronic Patient Reported Outcomes (ePRO) in Migraine and Headache Patient Populations," June 12, at 10-11am and 2-3pm EDT. PHT is the leading provider of innovative technology systems used to collect patient-driven eData for clinical research. The webinar is designed for professionals involved in Protocol Development, Regulatory Affairs, Health Outcomes, Clinical Operations, Medical Affairs, Data Management, and CNS. Migraine and headache patient diary compliance is an important component for obtaining accurate and high-quality clinical research data. Patient reported outcome (PRO) and electronic PRO (ePRO) measures are standard tools for directly eliciing the patient experience for Clinical Outcome Assessments (COAs). The 2009 FDA Guidance for Industry Patient Reported Outcome Measures: Use in Medical Product Development to Support Label Claims highlights the importance of PROs and other Clinical Outcome Assessment (COAs) in clinical research. PRO and ePRO are increasingly becoming an important part of migraine and headache clinical trials especially with regard to collecting information around migraine/headache frequency, duration, and severity. The electronic diary can be used as a daily record of migraines and headaches in prophylactic treatment studies or used to measure the effect of a treatment at distinct intervals after study drug administration in episodic treatment studies. The webinar will focus on the current use of COAs in migraine and headache studies, including review of:
Register at http://bit.ly/13iP670 Dr. Susan Dallabrida has 20+ years of experience in clinical trial design, strategy, and research and product development in a wide range of therapeutic areas. She is an experienced senior scientist and project leader in R&D and has led multiple cross-functional drug discovery and product development teams and collaborations. Dr. Dallabrida has 20 peer-reviewed articles, 14 grants, 3 patents, 22 abstracts, 31 conference presentations, and 17 awards. She received a B.A. in Chemistry and a B.S. in Biology, both cum laude, from Bloomsburg University; and a Ph.D. in Biochemistry and Molecular Biology from Pennsylvania State University. Dr. Jill Platko is an expert in laboratory information system management and clinical research systems with more than 16 years of advanced training in molecular biology at Cornell University, Genome Therapeutics Corporation, Whitehead Institute Center for Genome Research and Harvard Medical School. She provides scientific guidance and review of all clinical trial protocols to determine ePRO data collection design and project complexities; and creates demonstration versions of software customized for each sponsor's clinical trial protocol. About PHT Consulting Services The PHT Consulting Services Team has more than 60 years of collective experience in ePROs and COAs. The Team facilitates biopharmaceutical researchers and clinicians to implement optimal ePRO/COA trial design strategies to ensure the success of drug development programs. PHT consults on all aspects of collecting COAs, with scientific, regulatory, data management and health outcome expertise. About PHT Corporation PHT Corporation helps pharmaceutical companies and CROs conduct clinical trial programs with greater confidence, ease and accuracy. Proven PHT eCOA (electronic Clinical Outcome Assessment) Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via the PHT StudyWorks™ online portal, provides sponsors and clinicians with a real time window into how patients feel and function. PHT has helped trial sponsors collect patient-driven eData in 600+ global trials resulting in 16 regulatory approvals. PHT offers the regulatory, technological, and scientific expertise today's market demands and patients deserve. Visit www.phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Twitter and YouTube (News - Alert).
|
